Bolt Biotherapeutics, Inc.
BOLT
$5.44
$0.29385.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.45% | 30.72% | -5.01% | 28.40% | -96.05% |
| Total Depreciation and Amortization | -13.03% | -6.34% | -3.18% | -3.72% | -0.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.47% | -63.66% | 68.84% | -52.23% | 38.20% |
| Change in Net Operating Assets | 30.67% | -196.91% | -106.92% | -132.58% | 121.02% |
| Cash from Operations | 28.19% | 7.38% | -3.32% | 13.48% | 3.64% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.57% | 11.09% | -28.18% | -5.40% | 76.45% |
| Cash from Investing | -25.83% | 18.96% | -28.63% | -4.80% | 76.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.02% | 154.68% | -168.38% | 63.51% | 129.63% |